07:00 | GSK | Transaction in Own Shares | RNS |
22.04.2025 07:00 | GSK | Transaction in Own Shares | RNS |
17.04.2025 17:00 | GSK | GSK receives approval from UK MHRA for Blenrep combination | Alliance |
17.04.2025 16:13 | GSK | Blenrep licensed by UK MHRA | RNS |
17.04.2025 15:30 | GSK | Director/PDMR Shareholding | RNS |
17.04.2025 09:16 | GSK | GSK gets US advisory panel backing for RSV and Meningitis vaccines | Alliance |
17.04.2025 07:10 | GSK | Arexvy now ACIP recommended for 50-59 at risk | RNS |
17.04.2025 07:05 | GSK | GSK 5-in-1 meningitis vaccine recommended in US | RNS |
17.04.2025 07:00 | GSK | Transaction in Own Shares | RNS |
16.04.2025 07:00 | GSK | Transaction in Own Shares | RNS |
15.04.2025 15:30 | GSK | Director/PDMR Shareholding | RNS |
15.04.2025 07:00 | GSK | Transaction in Own Shares | RNS |
14.04.2025 15:30 | GSK | Director/PDMR Shareholding | RNS |
14.04.2025 07:00 | GSK | Transaction in Own Shares | RNS |
11.04.2025 15:30 | GSK | Director/PDMR Shareholding | RNS |
11.04.2025 07:00 | GSK | Transaction in Own Shares | RNS |
10.04.2025 07:00 | GSK | Transaction in Own Shares | RNS |
09.04.2025 07:00 | GSK | Transaction in Own Shares | RNS |
08.04.2025 07:00 | GSK | Transaction in Own Shares | RNS |
07.04.2025 09:46 | BWY, CRST, ABDN | LONDON BROKER RATINGS: Barclays upgrades Mondi; RBC ups Currys target | Alliance |
07.04.2025 07:00 | GSK | Transaction in Own Shares | RNS |
04.04.2025 07:00 | GSK | Transaction in Own Shares | RNS |
03.04.2025 14:17 | TRI, TCAP, STJ | UK dividends calendar - next 7 days | Alliance |
03.04.2025 07:00 | GSK | Transaction in Own Shares | RNS |
02.04.2025 07:00 | GSK | Transaction in Own Shares | RNS |
01.04.2025 15:30 | GSK | Total Voting Rights | RNS |
01.04.2025 07:00 | GSK | Transaction in Own Shares | RNS |
31.03.2025 07:00 | GSK | Transaction in Own Shares | RNS |
28.03.2025 15:30 | GSK | Director/PDMR Shareholding | RNS |
28.03.2025 08:48 | GSK, HLN | IN BRIEF: Haleon initiates first tranche of GBP330 million buyback | Alliance |
28.03.2025 07:00 | GSK | Transaction in Own Shares | RNS |
27.03.2025 07:00 | GSK | Transaction in Own Shares | RNS |
26.03.2025 07:00 | GSK | Transaction in Own Shares | RNS |
25.03.2025 18:30 | GSK | GSK urinary tract infection drug Blujepa approved by US regulator | Alliance |
25.03.2025 16:34 | GSK | GSK uUTI treatment approved by US FDA | RNS |
25.03.2025 07:00 | GSK | Transaction in Own Shares | RNS |
24.03.2025 16:10 | GSK | Notice of AGM | RNS |
24.03.2025 08:28 | GSK | GSK has application to expand use of mepolizumab accepted by EMA | Alliance |
21.03.2025 15:30 | GSK | Director/PDMR Shareholding | RNS |
21.03.2025 07:00 | GSK | Transaction in Own Shares | RNS |
20.03.2025 07:00 | GSK | Transaction in Own Shares | RNS |
19.03.2025 07:00 | GSK | Transaction in Own Shares | RNS |
18.03.2025 07:00 | GSK | Transaction in Own Shares | RNS |
17.03.2025 07:00 | GSK | Transaction in Own Shares | RNS |
14.03.2025 15:30 | GSK | Director/PDMR Shareholding | RNS |
14.03.2025 07:00 | GSK | Transaction in Own Shares | RNS |
13.03.2025 07:00 | GSK | Transaction in Own Shares | RNS |
12.03.2025 07:00 | GSK | Transaction in Own Shares | RNS |
11.03.2025 07:00 | GSK | Transaction in Own Shares | RNS |
10.03.2025 07:00 | GSK | Transaction in Own Shares | RNS |
07.03.2025 07:00 | GSK | Transaction in Own Shares | RNS |
06.03.2025 07:00 | GSK | Transaction in Own Shares | RNS |
05.03.2025 07:00 | GSK | Transaction in Own Shares | RNS |
04.03.2025 07:00 | GSK | Transaction in Own Shares | RNS |
03.03.2025 17:15 | GSK | GSK plc 2024 Annual Report on Form 20-F | RNS |
03.03.2025 15:00 | GSK | Total Voting Rights | RNS |
03.03.2025 09:56 | GSK | GSK says US FDA accepts two depemokimab indication submissions | Alliance |
03.03.2025 07:05 | GSK | US FDA accept 2 depemokimab indication submissions | RNS |
03.03.2025 07:00 | GSK | ANCHOR results presented at 2025 AAAAI | RNS |
03.03.2025 07:00 | GSK | Transaction in Own Shares | RNS |
28.02.2025 07:00 | GSK | Transaction in Own Shares | RNS |
27.02.2025 10:00 | GSK | GSK publishes Annual Report 2024 | RNS |
27.02.2025 07:00 | GSK | Transaction in Own Shares | RNS |
26.02.2025 16:00 | GSK | Director/PDMR Shareholding | RNS |
26.02.2025 07:00 | GSK | Transaction in Own Shares | RNS |
25.02.2025 07:00 | GSK | Transaction in Own Shares | RNS |
24.02.2025 08:32 | GSK | GSK completes GBP1 billion IDRx purchase; starts GBP2 billion buyback | Alliance |
24.02.2025 07:05 | GSK | GSK completes acquisition of IDRx, Inc. | RNS |
24.02.2025 07:00 | GSK | GSK plc commences share buyback programme | RNS |
21.02.2025 09:00 | GSK | IN BRIEF: GSK adds Oxford University medical science head to board | Alliance |
21.02.2025 07:00 | GSK | Directorate Change | RNS |
21.02.2025 07:00 | GSK | Director/PDMR Shareholding | RNS |
21.02.2025 07:00 | GSK | Director/PDMR Shareholding | RNS |
21.02.2025 07:00 | GSK | Director/PDMR Shareholding | RNS |
21.02.2025 07:00 | GSK | Director/PDMR Shareholding | RNS |